Literature DB >> 22293332

Hepatectomy for hepatocellular carcinoma patients with macronodular cirrhosis.

Qing-an Zeng1, Jiliang Qiu, Jian Hong, Yi Li, Shengping Li, Ruhai Zou, Pinzhu Huang, Binkui Li, Yun Zheng, Xiangming Lao, Yunfei Yuan.   

Abstract

OBJECTIVE: Patients with hepatocellular carcinoma (HCC) presenting with nonmicronodular or micronodular cirrhosis are usually treated by hepatectomy. The value of resection for patients with hepatitis B virus-related macronodular cirrhosis, however, remains unknown because of potentially fatal complications of this procedure.
METHODS: Clinicopathological data were analyzed for 85 resected HCC patients with hepatitis B virus-related macronodular cirrhosis. An additional 255 patients with nonmicronodular and micronodular cirrhosis were randomly selected during the same period as the control group.
RESULTS: Compared with nonmicronodular and micronodular cirrhosis patients, macronodular cirrhotic patients exhibited elevated alanine aminotransferase, aspartate aminotransferase, and γ-glutamyltransferase levels, higher Child-Pugh classification, higher indocyanine green retention rate at 15 min (ICG R15), and more number of total complications. No significant differences were observed between the two groups with regard to major complications, mortality, overall survival, and recurrence-free survival. The morbidity rate was relatively low in patients exhibiting low ICG R15 (<10%). Cox analysis identified small tumors (≤ 5 cm) and radical resection as independent prognostic factors that could predict long-term overall survival. Radical resection can result in high recurrence-free survival in macronodular cirrhotic patients.
CONCLUSION: Resection is safe for macronodular cirrhotic HCC patients, and radical resection provides a positive outcome. Small-sized patients are good candidates for hepatectomy. Macronodular cirrhosis should not rule out hepatectomy in patients with low ICG R15.

Entities:  

Mesh:

Year:  2012        PMID: 22293332     DOI: 10.1097/MEG.0b013e328351046a

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  4 in total

1.  High Levels of Gamma-Glutamyl Transferase and Indocyanine Green Retention Rate at 15 min as Preoperative Predictors of Tumor Recurrence in Patients With Hepatocellular Carcinoma.

Authors:  Peipei Song; Yoshinori Inagaki; Zhigang Wang; Kiyoshi Hasegawa; Yoshihiro Sakamoto; Junichi Arita; Wei Tang; Norihiro Kokudo
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

2.  Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center.

Authors:  Liangliang Xu; Lian Li; Peng Wang; Ming Zhang; Yanfang Zhang; Xiangyong Hao; Lvnan Yan; Bo Li; Tianfu Wen; Mingqing Xu
Journal:  Gut Liver       Date:  2019-11-15       Impact factor: 4.519

3.  HabibTM 4X-assisted resection versus clamp-crush resection for hepatocellular carcinoma: a propensity-matching study.

Authors:  Jiliang Qiu; Weiqun Lu; Nanrong Yu; Guohua Yang; Yi Li; Zhiliang Huang; Jianchang Li; Kefei Li; Houwei Xu; Shicai Chen; Xiang Zeng; Haiying Liu
Journal:  Oncotarget       Date:  2017-01-17

4.  Evaluating the role of RAD52 and its interactors as novel potential molecular targets for hepatocellular carcinoma.

Authors:  Ping Li; YanZhen Xu; Qinle Zhang; Yu Li; Wenxian Jia; Xiao Wang; Zhibin Xie; Jiayi Liu; Dong Zhao; Mengnan Shao; Suixia Chen; Nanfang Mo; Zhiwen Jiang; Liuyan Li; Run Liu; Wanying Huang; Li Chang; Siyu Chen; Hongtao Li; Wenpu Zuo; Jiaquan Li; Ruoheng Zhang; Xiaoli Yang
Journal:  Cancer Cell Int       Date:  2019-11-06       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.